Effects of Travoprost on Neovascular Glaucoma
Sponsor
Federal University of São Paulo (Other)
Overall Status
Withdrawn
CT.gov ID
NCT00441181
Collaborator
(none)
40
1
11
3.6
Study Details
Study Description
Brief Summary
Prostaglandin analogues have not been used in the treatment of neovascular glaucoma because of suspicious lack of efficacy. This study aims at assessing the effect of travoprost on neovascular glaucoma.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
| N/A |
Study Design
Study Type:
Interventional
Anticipated Enrollment
:
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double
Primary Purpose:
Treatment
Official Title:
Effects of Travoprost on Neovascular Glaucoma
Study Start Date
:
Jan 1, 2008
Anticipated Study Completion Date
:
Dec 1, 2008
Outcome Measures
Primary Outcome Measures
- Intraocular pressure []
Secondary Outcome Measures
- Inflammation []
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Neovascular glaucoma of known cause
-
Older than 18 years
-
Previously submitted to retinal photocoagulation
-
Under medical treatment to glaucoma
Exclusion Criteria:
-
Need of antiglaucomatous surgery
-
Previous ocular surgery in the last 6 months
-
Pregnancy
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Federal University of São Paulo | São Paulo | Brazil | 04023-900 |
Sponsors and Collaborators
- Federal University of São Paulo
Investigators
- Principal Investigator: Luiz A Melo Jr, MD, Federal University of São Paulo
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00441181
Other Study ID Numbers:
- UNIFESP 2007-02
First Posted:
Feb 28, 2007
Last Update Posted:
Jun 22, 2011
Last Verified:
Feb 1, 2007
Keywords provided by ,
,
Additional relevant MeSH terms: